| Literature DB >> 23897813 |
Elena Odintsova1, Guillaume van Niel2, Hélène Conjeaud3, Graça Raposo2, Ryo Iwamoto4, Eisuke Mekada4, Fedor Berditchevski5.
Abstract
Ligand-induced ubiquitylation of EGF receptor (EGFR) is an important regulatory mechanism that controls endocytic trafficking of the receptor and its signaling potential. Here we report that tetraspanin CD82/KAI1 specifically suppresses ubiquitylation of EGFR after stimulation with heparin-binding EGF or amphiregulin and alters the rate of recruitment of the activated receptor to EEA1-positive endosomes. The suppressive effect of CD82 is dependent on the heparin-binding domain of the ligand. Deletion of the C-terminal cytoplasmic domain of CD82 (CD82ΔC mutant) inhibits endocytic trafficking of the tetraspanin and compromises its activity toward heparin-binding EGF-activated EGFR. Reduced ubiquitylation of EGFR is accompanied by PKC-dependent increase in serine phosphorylation of c-Cbl in cells expressing elevated levels of CD82. Furthermore, phosphorylation of threonine 654 (PKC phosphorylation site) in the juxtamembrane domain of the receptor is considerably increased in CD82-expressing cells. These results describe previously unsuspected links between tetraspanin proteins and ubiquitylation of their molecular partners (e.g., EGFR). Our data identify CD82 as a new regulator of c-Cbl, which discriminatively controls the activity of this E3 ubiquitin ligase toward heparin-binding ligand-EGFR pairs. Taken together, these observations provide an important new insight into the modulatory role of CD82 in endocytic trafficking of EGF receptor.Entities:
Keywords: CD82; Epidermal Growth Factor Receptor (EGFR); Heparin-binding Protein; Tetraspanins; Trafficking; Ubiquitylation
Mesh:
Substances:
Year: 2013 PMID: 23897813 PMCID: PMC3764837 DOI: 10.1074/jbc.M112.439380
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157